Minerva Neurosciences, Inc. Increase (Decrease) in Prepaid Expense
Minerva Neurosciences, Inc. (NERV) reported Increase (Decrease) in Prepaid Expense of -$897.74 thousand for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2016-08-04
- Minerva Neurosciences, Inc. increase (decrease) in prepaid expense for the quarter ending 2016-06-30 was -$331.53K.
- Minerva Neurosciences, Inc. increase (decrease) in prepaid expense for the quarter ending 2016-03-31 was -$566.21K.
- Minerva Neurosciences, Inc. increase (decrease) in prepaid expense for the quarter ending 2015-06-30 was -$194.34K.
- Minerva Neurosciences, Inc. increase (decrease) in prepaid expense for the quarter ending 2015-03-31 was -$253.66K, a 13015.58% decline year-over-year.
- Minerva Neurosciences, Inc. increase (decrease) in prepaid expense for fiscal 2014 was $713.20K.
- Minerva Neurosciences, Inc. increase (decrease) in prepaid expense for fiscal 2013 was -$8.14K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|
| 2016-06-30 | -$331.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$897.74K 10-Q · filed 2016-08-04 | ||
| 2016-03-31 | -$566.21K 10-Q · filed 2016-05-03 | |||
| 2015-06-30 | -$194.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$448.00K 10-Q · filed 2016-08-04 | -$274.56K derived: sum of 3 quarters · filed 2016-08-04 | $275.76K derived: sum of 4 quarters · filed 2016-08-04 |
| 2015-03-31 | -$253.66K 10-Q · filed 2016-05-03 | -$80.22K derived: sum of 2 quarters · filed 2016-05-03 | $470.10K derived: sum of 3 quarters · filed 2016-05-03 | $457.57K derived: sum of 4 quarters · filed 2016-05-03 |
| 2014-12-31 | $173.44K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $723.76K derived: sum of 2 quarters · filed 2015-03-26 | $711.24K derived: sum of 3 quarters · filed 2015-03-26 | $713.20K 10-K · filed 2015-03-26 |
| 2014-09-30 | $550.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $537.80K derived: sum of 2 quarters · filed 2014-11-06 | $539.76K 10-Q · filed 2014-11-06 | $538.74K derived: sum of 4 quarters · filed 2015-05-07 |
| 2014-06-30 | -$12.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$10.56K 10-Q · filed 2014-08-07 | -$11.58K derived: sum of 3 quarters · filed 2015-05-07 | |
| 2014-03-31 | $1.96K 10-Q · filed 2015-05-07 | $946.00 derived: sum of 2 quarters · filed 2015-05-07 | ||
| 2013-12-31 | -$1.02K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | -$8.14K 10-K · filed 2015-03-26 | ||
| 2013-09-30 | -$7.13K 10-Q · filed 2014-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |